Britannia Life Sciences Inc BLAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.07
- Day Range
- CAD 0.08–0.08
- 52-Week Range
- CAD 0.03–0.13
- Bid/Ask
- CAD 0.07 / CAD 0.08
- Market Cap
- CAD 12.98 Mil
- Volume/Avg
- 71,000 / 96,312
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.73
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Britannia Life Sciences Inc is a diversified product development, quality assurance, and safety & regulatory compliance company supporting clients in the CPG, cosmetics, household goods, and nutraceutical industries in the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.britannia.life
Valuation
|
Metric
|
BLAB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.64 |
Price/Sales | 1.73 |
Price/Cash Flow | 17.64 |
Price/Earnings
BLAB
Financial Strength
|
Metric
|
BLAB
|
|---|---|
Quick Ratio | 0.53 |
Current Ratio | 0.55 |
Interest Coverage | 2.68 |
Quick Ratio
BLAB
Profitability
|
Metric
|
BLAB
|
|---|---|
Return on Assets (Normalized) | 0.64% |
Return on Equity (Normalized) | 2.79% |
Return on Invested Capital (Normalized) | 6.62% |
Return on Assets
BLAB
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vhzyjlszm | Jgmrm | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jlljfldcc | Hcwdktm | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fdxxdpgd | Pqhsch | $108.2 Bil | |
MRNA
| Moderna Inc | Dgjjygw | Yhmz | $50.9 Bil | |
ARGX
| argenx SE ADR | Xyryrznb | Hjcj | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Dppjqdsrx | Lcrc | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lxdcmqv | Wllkpc | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Mhhfdvpry | Ljggv | $14.6 Bil | |
INCY
| Incyte Corp | Wfxgljq | Zlqht | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Cgzygjft | Vsmhvf | $12.3 Bil |